Dysphagia in the setting of left ventricular assist device hemolysis

ASAIO J. 2013 May-Jun;59(3):322-3. doi: 10.1097/MAT.0b013e31828bbb00.

Abstract

A 69-year-old man with advanced heart failure treated with a continuous-flow left ventricular assist device presented for evaluation of dark urine and severe dysphagia. Because of evidence of ongoing intravascular hemolysis with device dysfunction, there was a clinical suspicion for pump thrombosis. He had progressive end-organ dysfunction and was therefore treated with tissue plasminogen activator with prompt resolution in hemolysis and dysphagia. Although symptoms of smooth muscle dystonia could represent worsening heart failure in the setting of device failure, the observation may also be related to intravascular hemolysis as described in the prototypic hemolytic disease, paroxysmal nocturnal hemoglobinuria.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Deglutition Disorders / drug therapy
  • Deglutition Disorders / etiology*
  • Diagnosis, Differential
  • Dystonia / complications*
  • Dystonia / drug therapy
  • Heart Failure / drug therapy
  • Heart Failure / surgery*
  • Heart-Assist Devices / adverse effects*
  • Hemoglobinuria, Paroxysmal / complications
  • Hemoglobinuria, Paroxysmal / diagnosis*
  • Hemoglobinuria, Paroxysmal / drug therapy
  • Hemolysis / drug effects*
  • Humans
  • Male
  • Muscle, Smooth / pathology*
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Tissue Plasminogen Activator